Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000058671) titled 'whole brain radiotherapy for metastatic brain tumors, scalp sparing radiotherapy using IMRT: multi-insitutional study' on Aug. 1.
Study Type: Interventional
Study Design:
Single arm Non-randomized
Primary Sponsor: Juntendo University
Condition:
metastatic brain tumor
Intervention:
Employing IMRT, reduce the dose to the scalp during whole brain radiotherapy
Recruitment Status: Recruiting
Phase: Phase II
Date of First Enrollment: 2023/03/24
Target Sample Size: 40
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067091
Publ...